CI vs CVS
CI and CVS side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CIThe Cigna Group | CVSCVS HEALTH CORPORATION |
|---|---|---|
| Market cap | $78.83B | $115.40B |
| P/E (TTM) | 12.3 | 23.8 |
| P/B | 1.85 | 1.45 |
| P/S | 0.3x | 0.3x |
| Dividend yield | 2.04% | 2.94% |
| Revenue | $282.38B(TTM) | $415.09B(TTM) |
| Revenue growth (YoY) | 11.2% | 7.8% |
| Net income | $6.42B(TTM) | $4.89B(TTM) |
| Earnings growth (YoY) | 73.5% | -61.7% |
| EPS, diluted | $24.18(TTM) | $3.79(TTM) |
| EBIT margin | 3.3% | 1.2% |
| ROE | 14.0% | 2.2% |
| ROIC | 9.5% | 2.9% |
| Piotroski F | — | 6/9 |
| 1y total return | +23.3% | +21.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CI frente a CVS
| Métrica | CI | CVS |
|---|---|---|
| Valor final | $25.8K | $13.2K |
| Retorno total | +157.6% | +31.7% |
| CAGR | +9.6% | +2.7% |
| Volatilidad | 30.6% | 28.8% |
| Sharpe | 0.32 | 0.09 |
| Sortino | 0.45 | 0.13 |
| Caída máxima | -42.5% | -56.8% |
Basado en 2600 días de negociación comunes, 2016-06-29 → 2026-10-30 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)